BlackRock Health Sciences Opportunities Portfolio Investor C Shares SHSCX

Morningstar Medalist Rating
  • NAV / 1-Day Return$52.02  /  +0.13%
  • Fund Size$6.6B
  • Adjusted Expense Ratio1.900%
  • Net Expense Ratio1.890%
  • Fee Level: DistributionBelow Average
  • Share Class TypeLevel Load
  • Morningstar CategoryHealth
  • Equity Style Box (Funds)Large Value
  • Minimum Initial Investment$1,000
  • Investment StatusOpen
  • TTM Yield0.00%
  • Turnover Ratio49%

Morningstar’s Analysis SHSCX

Will SHSCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BlackRock Health Sciences Opps Inv C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings SHSCX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings54.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.13760M
Healthcare

Johnson & Johnson

8.13510M
Healthcare

Merck & Co Inc

5.57349M
Healthcare

AbbVie Inc

5.27330M
Healthcare

Thermo Fisher Scientific Inc

4.91308M
Healthcare

Gilead Sciences Inc

4.24266M
Healthcare

Amgen Inc

3.97249M
Healthcare

UnitedHealth Group Inc

3.89244M
Healthcare

Danaher Corp

3.50219M
Healthcare

Vertex Pharmaceuticals Inc

3.26204M
Healthcare

Sponsor Center